pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,774 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT834Endpoints640BioPharma Dive243onclive165BioSpace98Fierce Biotech96raps39globenewswire health28fda recalls
therapy area
allOncology5005Rare Disease852Cardiology802Hematology772Immunology736Psychiatry & CNS582Pulmonology
  • STAT+: DOJ, Elevance spar over access to top exec in Medicare Advantage fraud case
    Elevance said a top exec would depart, days after the Justice Department asked to depose him.
    STAT · 3mo ago↗ source
  • Avalyn's upsized IPO; Alector ends another study in GSK partnership
    🔔 Avalyn Pharma’s $300M IPO: The Boston, MA-based biotech is selling over 16.5 million shares at $18 apiece. The company is set to start trading as {$AVLN} on the Nasdaq Thursday ...
    Endpoints · 3mo ago↗ source
  • Analysts focus on three programs in big year for Bristol Myers
    Wall Street’s expectations for Bristol Myers Squibb’s upcoming slate of data readouts are reaching a fever pitch. Analysts lobbed questions regarding at least half a dozen trial results expected by…
    Endpoints · 3mo ago
← prev
page 66 of 71
next →
23
fda press21
fda medwatch18
573
Vaccines517
Endocrinology & Metabolism293
Ophthalmology265
Infectious Disease253
Nephrology239
↗ source
  • STAT+: Hinge has a new FDA-cleared migraine device
    In this edition of STAT Health Tech: FDA's plan to use AI to speed up trials, Hinge's new migraine device, and boosting cancer screening with texts.
    STAT · 3mo ago↗ source
  • XTL Bio to acquire psychedelic biotech; WuXi AppTec’s Q1 revenue rise
    Plus, news about PCI Pharma: 🏭 XTL Bio steps into psychedelics: XTL Biopharmaceuticals is acquiring 100% of the outstanding shares of psychedelic-focused biotech Psyga Bio. XTL will gain Psyga’s m…
    Endpoints · 3mo ago↗ source
  • STAT+: Cigna will exit ACA individual markets next year, adding to tumult for patients
    ACA membership is tumbling after Congress failed to extend extra subsidies that helped people afford the coverage.
    STAT · 3mo ago↗ source
  • STAT+: Democrats go hard on health care affordability
    The Senate's top Democrat unveiled a health policy outline that calls for lowering patients' costs across the board.
    STAT · 3mo ago↗ source
  • What we heard at a health tech conference in Boston
    I just came back from the Digital Healthcare Innovation Summit in Boston earlier this week, where I got a good look into what investors are thinking about. A few impressions: Investors see a ...
    Endpoints · 3mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about a Supreme Court hearing on ‘skinny labels,’ AstraZeneca U.K. expansion, and more
    AstraZeneca will resume expansion of its U.K. R&D operations after the trade deal with the U.S. included measures to lift U.K. drug spending
    STAT · 3mo ago↗ source
  • CVS' healthcare delivery chief eyes potential in clinical AI
    CVS Health has been testing AI tools that deliver healthcare, though it sees too many barriers to using them more widely for now. CVS' President of Health Care Delivery Sree Chaguturu told Endpoint…
    Endpoints · 3mo ago↗ source
  • Smog from wildfires increasingly harmful, data show
    American baby formula testing, Medicaid work requirements, and more Morning Rounds health news
    STAT · 3mo ago↗ source
  • Updated: Early sales of Lilly’s obesity pill appear to trail Novo’s
    About 20,000 people are taking Eli Lilly’s obesity pill Foundayo after its first 20 days on the market, according to the company’s CEO David Ricks. This points to a markedly slower launch of the dr…
    Endpoints · 3mo ago↗ source
  • The R&D 15: How pharma's top companies spent, won and lost on drug research
    Talking over pharma pipelines with a major drugmaker's development chief, he noted that if you looked at the biggest 50 drugs by revenue, the final one on the list brought in about $4 billion last ...
    Endpoints · 3mo ago↗ source
  • Novartis unveils North Carolina factory as final new build in $23B US expansion
    Novartis on Thursday revealed its plans to build another factory in the US, with the Swiss drugmaker noting that it has now allocated every dollar of its $23 billion promise to expand ...
    Endpoints · 3mo ago↗ source
  • STAT+: What does Akeso’s primo plenary spot say about its survival data?
    Mystery cloaks an ASCO plenary lung cancer survival result.
    STAT · 3mo ago↗ source
  • STAT+: New obesity tool aims to predict risk of 18 serious complications
    A new tool, OBSCORE, is meant to better define who's at risk for obesity complications, going beyond BMI to include family history, diet, and more.
    STAT · 3mo ago↗ source
  • Opinion: Are international medical graduates taking residency spots from Americans? We did the math
    A new social media narrative claims international grads are stealing American doctors’ jobs. These authors did the math to figure out if it’s true.
    STAT · 3mo ago↗ source
  • Securing NIH awards is getting more competitive — and confusing
    The likelihood of snagging NIH grants has plunged to historic lows, forcing academic researchers to resort to a variety of tactics to try to obtain funding
    STAT · 3mo ago↗ source
  • Opinion: Congress must hold RFK Jr. accountable after hearings
    Michael Burgess and Larry Bucshon, former Republican congressmen and doctors, weigh in on RFK Jr.’s recent congressional hearings.
    STAT · 3mo ago↗ source
  • HHS appeals ruling that stalled many of Kennedy’s vaccine policy changes
    The appeal is the latest twist in the closely watched lawsuit filed by the American Association of Pediatrics.
    STAT · 3mo ago↗ source
  • STAT+: Supreme Court justices appear to signal ‘skinny labeling’ can survive
    At Wednesday's argument, the justices did not appear to question whether skinny labeling is valid.
    STAT · 3mo ago↗ source
  • AbbVie faces questions about Skyrizi competition from J&J
    Threats to AbbVie's immunology dominance took center stage on the company's first-quarter earnings call Wednesday morning, as analysts pressed executives on their defense strategy. The heart of the…
    Endpoints · 3mo ago↗ source
  • FDA, AstraZeneca prep for oncology adcomm
    The FDA is set to convene its first advisory meeting of oncology experts in about nine months, with a couple of AstraZeneca drugs as the focus of the discussion. Details about the meeting of the ...
    Endpoints · 3mo ago↗ source
  • STAT+: Why conversations around health AI may be evolving beyond hype
    In this edition of AI Prognosis, Brittany Trang argues that the tide may be turning when it comes to how the health care industry talks about AI.
    STAT · 3mo ago↗ source
  • Bristol Myers reaches a crossroads as a make-or-break year takes shape
    Bristol Myers Squibb is facing a bit of an identity crisis. CEO Chris Boerner is nearly two and a half years into his tenure, with most of his time defined by
    Endpoints · 3mo ago↗ source